Disclosures for "MoCA as a Measure of Cognitive Outcomes in Progressive Supranuclear Palsy (PSP)"
-
Miss Ibrahim has nothing to disclose.
-
Dr. Isroff has nothing to disclose.
-
Mr. Iyer has nothing to disclose.
-
The institution of Dr. Bayram has received research support from National Institute on Aging (K99AG073453). The institution of Dr. Bayram has received research support from Lewy Body Dementia Association. The institution of Dr. Bayram has received research support from National Institute of Neurological Disorders and Stroke.
-
Dr. Montaser-Khousari has received personal compensation in the range of $0-$499 for serving as a Consultant for Darmyian, Trinity Life Sciences, Guidepoint and Techspert. Dr. Montaser-Khousari has received research support from DoD.
-
Dr. Swan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACME. The institution of Dr. Swan has received research support from Sanofi Genzyme. The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics.
-
Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergic Medical Technologies . Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. The institution of Dr. Dale has received research support from NIH . The institution of Dr. Dale has received research support from Collins Medical Trust.
-
Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
-
Dr. Golbe has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aprinoia. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ferrer. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitochon. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Rossy Centre. Dr. Golbe has received intellectual property interests from a discovery or technology relating to health care. Dr. Golbe has received publishing royalties from a publication relating to health care. Dr. Golbe has a non-compensated relationship as a Chief Clinical Officer, Scientific Advisory Board Chair, Member of the Board of Directors, all as a volunteerd with CurePSP that is relevant to AAN interests or activities.
-
Doug Gunzler has received publishing royalties from a publication relating to health care.
-
Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics.